Gary J Doherty - Department of Oncology, Cambridge University Hospitals NHS Foundation Trust

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 57 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Differential Safety Profiles of Durvalumab Monotherapy and Durvalumab in Combination with Tremelimumab in Adult Patients with Advanced Cancers

Claire Morgan, John Kurland, Mayur Patel, Cathy O'Brien, Pamela Concepcion,Gary J Doherty, Stephan Hois,Alejandra Negro, Dejan Pavlovic, Karen A Robbins

Journal for immunotherapy of cancerno. 5 (2025)

Cited0Views0WOSBibtex

Machine Learning Modeling of Patient Health Signals Informs Long-Term Survival on Immune Checkpoint Inhibitor Therapy

Gerald J. Sun,Gustavo Arango-Argoty,Gary J. Doherty, Damian E. Bikiel, Dejan Pavlovic, Allen C. Chen,Ross A. Stewart,Zhongwu Lai,Etai Jacob

iScienceno. 9 (2024): 110634-110634

Cited1Views0WOSBibtex

Outcomes with Perioperative Durvalumab (D) in Pts with Resectable NSCLC and Baseline N2 Lymph Node Involvement (N2 R-NSCLC): an Exploratory Subgroup Analysis of AEGEAN

John Heymach,Martin Reck,Tetsuya Mitsudomi,Janis M. Taube,Alexander I. Spira,Jamie E. Chaft,Gary J. Doherty,Helen Mann,Tamer M. Fouad,David H. Harpole

Journal of Clinical Oncologyno. 16_suppl (2024): 8011-8011

Cited0Views0Bibtex

BMScope: A Scoping Review to Chart the Evolving Clinical Study Landscape in Brain and Leptomeningeal Metastasis

R. Heywood, V Cheng,R. Zakaria,R. Burger,K. Zucker, S. Kannan, M. Putra,A. Fitzpatrick,G. Doherty,P. Sanghera,M. Jenkinson,C. Palmieri

NEURO-ONCOLOGY (2024): V87-V87

Cited0Views0WOSBibtex

Abstract CT238: Associations of Ctdna Levels During Neoadjuvant Treatment with Pathological Response in Patients with Resectable NSCLC from the Phase 3 AEGEAN Trial

Davina Gale,Zhou Zhu,Zhongwu Lai,Martin Reck,David H. Harpole,Janis M. Taube,Tetsuya Mitsudomi,Maximilian J. Hochmair,Thomas Winder,László Urbán,Jerónimo Rafael Rodríguez‐Cid,Quincy Chu,Jamie E. Chaft,Ross Stewart,Darren Hodgson,Gary J. Doherty,John V. Heymach

Cancer Researchno. 7_Supplement (2024): CT238-CT238

Cited0Views0Bibtex

Implementing Circulating Tumor DNA As a Prognostic Biomarker in Resectable Non-Small Cell Lung Cancer

Chris Abbosh,Darren Hodgson,Gary J. Doherty,Davina Gale,James R.M. Black,Leora Horn,Jorge S. Reis-Filho,Charles Swanton

Trends in cancerno. 7 (2024): 643-654

Cited4Views0WOSBibtex

Ctdna Dynamics and Neoadjuvant Treatment Responses in Patients with Resectable NSCLC from the Phase 3 AEGEAN Trial

Christian Schumann,John V. Heymach,David Harpole,Testuya Mitsudomi,Janis M. Taube,Gabriella Galffy,Maximilian Hochmair,Thomas Winder,Ruslan Zukov, Gabriel Garbaos,Shugeng Gao,Hiroaki Kuroda,Jian You,Kang-Yun Lee,Lorenzo Antonuzzo, Mike Aperghis,Gary J. Doherty,Helen Mann,Tamer M. Fouad,Martin Reck, Silvan Becker

ONCOLOGY RESEARCH AND TREATMENT (2024): 126-127

Cited0Views0Bibtex

Abstract CT005: AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC

John V. Heymach,David Harpole,Tetsuya Mitsudomi, Janis M. Taube,Gabriella Galffy,Maximilian Hochmair,Thomas Winder,Ruslan Zukov, Gabriel Garbaos,Shugeng Gao,Hiroaki Kuroda,Jian You,Kang-Yun Lee, Lorenzo Antonuzzo, Mike Aperghis,Gary J. Doherty,Helen Mann,Tamer M. Fouad,Martin Reck

Cancer Researchno. 8_Supplement (2023)

Cited42Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn